UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Chlamydia trachomatis prevalence, genotype distribution and identification of the new Swedish variant in Southern Germany

Infection, 2013-02, Vol.41 (1), p.159-166

2013

Volltextzugriff (PDF)

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)

Annals of oncology, 2013-09, Vol.24 (9), p.2278-2284

2013

Volltextzugriff (PDF)

RAMBO-K: Rapid and Sensitive Removal of Background Sequences from Next Generation Sequencing Data

PloS one, 2015-09, Vol.10 (9), p.e0137896-e0137896

2015

Volltextzugriff (PDF)

Reliable variant calling during runtime of Illumina sequencing

Scientific reports, 2019-11, Vol.9 (1), p.16502-8, Article 16502

2019

Volltextzugriff (PDF)

Secondary resistance to idelalisib is characterized by upregulation of IGF1R rather than by MAPK/ERK pathway mutations

Blood, 2022-06, Vol.139 (22), p.3340-3344

2022

Volltextzugriff (PDF)

PAIPline: pathogen identification in metagenomic and clinical next generation sequencing samples

Bioinformatics, 2018-09, Vol.34 (17), p.i715-i721

2018

Volltextzugriff (PDF)

LiveKraken--real-time metagenomic classification of illumina data

Bioinformatics, 2018-11, Vol.34 (21), p.3750-3752

2018

Volltextzugriff (PDF)

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

The New England journal of medicine, 2019-02, Vol.380 (7), p.617-628

2019

Volltextzugriff (PDF)

Global Disparities in Breast Cancer Genetics Testing, Counselling and Management

World journal of surgery, 2019-05, Vol.43 (5), p.1264-1270

2019

Volltextzugriff (PDF)

PathoLive—Real-Time Pathogen Identification from Metagenomic Illumina Datasets

Life (Basel, Switzerland), 2022-08, Vol.12 (9), p.1345

2022

Volltextzugriff (PDF)

Proficiency Testing of Metagenomics-Based Detection of Food-Borne Pathogens Using a Complex Artificial Sequencing Dataset

Frontiers in microbiology, 2020-11, Vol.11, p.575377-575377

2020

Volltextzugriff (PDF)

HiLive: real-time mapping of illumina reads while sequencing

Bioinformatics (Oxford, England), 2017-03, Vol.33 (6), p.917-319

2017

Volltextzugriff (PDF)

PriLive: privacy-preserving real-time filtering for next-generation sequencing

Bioinformatics, 2018-07, Vol.34 (14), p.2376-2383

2018

Volltextzugriff (PDF)

VENETOCLAX‐OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 6‐YEAR RESULTS OF THE RANDOMIZED CLL14 STUDY

Hematological oncology, 2023-06, Vol.41 (S2), p.58-60

2023

Volltextzugriff (PDF)

Photonen und Molekule

Chemkon, 2017-10, Vol.24 (4), p.265

2017

Volltextzugriff (PDF)

Photonen und Moleküle: Innovation trifft Tradition

Chemkon, 2017, Vol.24 (4), p.265-271

2017

Volltextzugriff (PDF)

Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy

Breast cancer research and treatment, 2018-12, Vol.172 (3), p.523-537

2018

Volltextzugriff (PDF)

Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study

Annals of surgical oncology, 2022-02, Vol.29 (2), p.1061-1070

2022

Volltextzugriff (PDF)

VENETOCLAX‐OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 4‐YEAR FOLLOW‐UP ANALYSIS OF THE RANDOMIZED CLL14 STUDY

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

S143: TRANSCRIPTOMIC CHARACTERIZATION OF MRD RESPONSE AND NON‐RESPONSE IN PATIENTS TREATED WITH FIXED‐DURATION VENETOCLAX‐OBINUTUZUMAB

HemaSphere, 2022-06, Vol.6, p.44-45

2022

Volltextzugriff (PDF)

S148: VENETOCLAX‐OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 5‐YEAR RESULTS OF THE RANDOMIZED CLL14 STUDY

HemaSphere, 2022-06, Vol.6, p.49-50

2022

Volltextzugriff (PDF)

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023

Hematological oncology, 2023-06, Vol.41 Suppl 2, p.58

2023

Volltextzugriff (PDF)

Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1

Haematologica (Roma), 2020-10, Vol.105 (10), p.2440

2020

Volltextzugriff (PDF)

HIGH EFFICACY OF VENETOCLAX PLUS OBINUTUZUMAB IN PATIENTS WITH COMPLEX KARYOTYPE (CKT) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A PROSPECTIVE ANALYSIS FROM THE CLL14 TRIAL

Hematological oncology, 2019-06, Vol.37 (S2), p.104-106

2019

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(45)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Chlamydia trachomatis prevalence, genotype distribution and identification of the new Swedish variant in Southern Germany

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)

RAMBO-K: Rapid and Sensitive Removal of Background Sequences from Next Generation Sequencing Data

Reliable variant calling during runtime of Illumina sequencing

Secondary resistance to idelalisib is characterized by upregulation of IGF1R rather than by MAPK/ERK pathway mutations

PAIPline: pathogen identification in metagenomic and clinical next generation sequencing samples

LiveKraken--real-time metagenomic classification of illumina data

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

Global Disparities in Breast Cancer Genetics Testing, Counselling and Management

PathoLive—Real-Time Pathogen Identification from Metagenomic Illumina Datasets

Proficiency Testing of Metagenomics-Based Detection of Food-Borne Pathogens Using a Complex Artificial Sequencing Dataset

HiLive: real-time mapping of illumina reads while sequencing

PriLive: privacy-preserving real-time filtering for next-generation sequencing

Retrospective multicenter analysis comparing conventional with oncoplastic breast conservation: oncologic and surgical outcome in women with high risk breast cancer from the OPBC-01/iTOP2 study

VENETOCLAX‐OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 6‐YEAR RESULTS OF THE RANDOMIZED CLL14 STUDY

Photonen und Molekule

Photonen und Moleküle: Innovation trifft Tradition

Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy

Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study

VENETOCLAX‐OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 4‐YEAR FOLLOW‐UP ANALYSIS OF THE RANDOMIZED CLL14 STUDY

S143: TRANSCRIPTOMIC CHARACTERIZATION OF MRD RESPONSE AND NON‐RESPONSE IN PATIENTS TREATED WITH FIXED‐DURATION VENETOCLAX‐OBINUTUZUMAB

S148: VENETOCLAX‐OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 5‐YEAR RESULTS OF THE RANDOMIZED CLL14 STUDY

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023

Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1

HIGH EFFICACY OF VENETOCLAX PLUS OBINUTUZUMAB IN PATIENTS WITH COMPLEX KARYOTYPE (CKT) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A PROSPECTIVE ANALYSIS FROM THE CLL14 TRIAL

Suchergebnisse filtern